Complex and Cryptic KMT2A :: MLLT10 Rearrangements in Acute Myeloid Leukemia Resolved by Optical Genome Mapping
Genes, Chromosomes and Cancer · 2026-11 · 65 (11)
DOI: 10.1002/gcc.70197 ↗Abstract
ABSTRACT Accurate identification of KMT2A::MLLT10 fusions is essential for diagnostic classification and prognostication in acute myeloid leukemia and can guide therapeutic decision making. Detection of these fusions is diagnostically challenging due to the frequently cryptic and structurally complex nature of these events. In this study, we evaluated acute leukemia cases undergoing diagnostic workup with karyotyping and optical genome mapping (OGM), identified cases with KMT2A::MLLT10 fusions and retrospectively analyzed the structural events. During the period from September 2023 to April 2025, a total of five acute myeloid leukemia cases were identified which had a KMT2A::MLLT10 fusion. While OGM identified a KMT2A::MLLT10 rearrangement in all five cases, karyotype analysis showed no evidence of a rearrangement involving the KMT2A locus on 11q23 in four cases and fluorescence in situ hybridization (FISH) showed a normal signal pattern using a KMT2A break‐apart probe in interphase nuclei in three cases. Additionally, OGM revealed the complexity of the rearrangement events underlying fusion formation, generally including inversions ranging from less than 1 megabase to over 20 megabases in size along with variably sized deletions around the translocation breakpoints. Our study reveals that KMT2A::MLLT10 rearrangements are characterized by complex, multi‐break events with variable sizes of inversions of the translocated segments resulting in in‐frame fusions. These events were often difficult to detect by standard karyotype and interphase FISH, highlighting the value of high‐resolution methods like OGM in resolving these structurally complex events.
EUVIMED